ISRCTN42553489已完成未知
Prophylactic granulocyte-macrophage colony-stimulating factor (GM-CSF) to reduce sepsis in preterm neonates: a randomised controlled trial
Imperial College London (UK)0 个研究点目标入组 320 人开始时间: 2001年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Babies are eligible for PROGRAMS if they are less than or equal to 31 completed weeks gestational age and small for gestational age (i.e. below 10th centile for birthweight) and within 72 hours of birth.
排除标准
- •Added 21/01/2009:
- •1. Immediately life-threatening congenital abnormality
- •2. Evidence of early onset sepsis (maternal pyrexia greater than 38.0°C on two consecutive occasions during labour)
研究者
相似试验
招募中
2 期
Effect of white blood cells enhancing factor on medulloblastoma (Brain tumor) patients receiving radiotherapyCTRI/2018/01/011292PGIMER
进行中（未招募）
1 期
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to prevent ARDS in COVID-19 pneumoniaEUCTR2020-001654-21-DEJustus-Liebig-University Gießen238
招募中
3 期
Administration of granulocyte colony-stimulating factor (G-CSF) to an unresponsive endometrium in an IVF cycleunresponsive endometriumReproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12611000907943Fertility Specialists of Western Australia50
已完成
4 期
The Effect of granulocyte colony-stimulating factor and erythropoietin on survival in patients with Acute-on-Chronic Liver Failure.Acute-on-Chronic Liver Failure.SLCTR/2018/015Dr. Md. Nazmul Haque
已完成
4 期
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients.eutropenia secondary to chemo and/or radiotherapy.RPCEC00000084Center of Molecular Immunology(CIM)372